Abstract
Purpose
UV exposure is the main risk factor for development of cutaneous squamous cell carcinoma (cSCC). While early detection greatly improves cSCC prognosis, locally advanced or metastatic cSCC has a severely impaired prognosis. Notably, the mechanisms of progression to metastatic cSCC are not well understood. We hypothesized that UV exposure of already transformed epithelial cSCC cells further induces changes which might be involved in the progression to metastatic cSCCs and that UV-inducible microRNAs (miRNAs) might play an important role.
Methods
Thus, we analyzed the impact of UV radiation of different quality (UVA, UVB, UVA + UVB) on the miRNA expression pattern in established cell lines generated from primary and metastatic cSCCs (Met-1, Met-4) using the NanoString nCounter platform.
Results
This analysis revealed that the expression pattern of miRNAs depends on both the cell line used per se and on the quality of UV radiation. Comparison of UV-induced miRNAs in cSCC cell lines established from a primary tumor (Met-1) and the respective (un-irradiated) metastasis (Met-4) suggest that miR-7-5p, miR-29a-3p and miR-183-5p are involved in a UV-driven pathway of progression to metastasis. This notion is supported by the fact that these three miRNAs build up a network of 81 potential target genes involved e.g. in UVA/UVB-induced MAPK signaling and regulation of the epithelial–mesenchymal transition. As an example, PTEN, a target of UV-upregulated miRNAs (miR-29a-3p, miR-183-5p), could be shown to be down-regulated in response to UV radiation. We further identified CNOT8, the transcription complex subunit 8 of the CCR4-NOT complex, a deadenylase removing the poly(A) tail from miRNA-destabilized mRNAs, in the center of this network, targeted by all three miRNAs.
Conclusion
In summary, our results demonstrate that UV radiation induces an miRNA expression pattern in primary SCC cell line partly resembling those of metastatic cell line, thus suggesting that UV radiation impacts SCC progression beyond initiation.
Similar content being viewed by others
References
Adams BD, Kasinski AL, Slack FJ (2014) Aberrant regulation and function of microRNAs in cancer. Curr Biol 24:R762–776. https://doi.org/10.1016/j.cub.2014.06.043
Almahroos M, Kurban AK (2004a) Ultraviolet carcinogenesis in nonmelanoma skin cancer part II: review and update on epidemiologic correlations. Skinmed 3:132–139
Almahroos M, Kurban AK (2004b) Ultraviolet carcinogenesis in nonmelanoma skin cancer. Part I: incidence rates in relation to geographic locations and in migrant populations. Skinmed 3:29–35 (quiz 35-26)
Anfossi S, Babayan A, Pantel K, Calin GA (2018) Clinical utility of circulating non-coding RNAs—an update. Nat Rev Clin Oncol. https://doi.org/10.1038/s41571-018-0035-x
Armstrong BK, Kricker A (2001) The epidemiology of UV induced skin cancer. J Photochem Photobiol B 63:8–18
Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857–866. https://doi.org/10.1038/nrc1997
Cha HJ et al (2014) Identification of ultraviolet B radiationinduced microRNAs in normal human dermal papilla cells. Mol Med Rep 10:1663–1670. https://doi.org/10.3892/mmr.2014.2418
Chakrabarti M, Khandkar M, Banik NL, Ray SK (2012) Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells. Brain Res 1454:1–13. https://doi.org/10.1016/j.brainres.2012.03.017
Chan LW, Wang FF, Cho WC (2012) Genomic sequence analysis of EGFR regulation by microRNAs in lung cancer. Curr Top Med Chem 12:920–926
Chen F, Hu SJ (2012) Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review. J Biochem Mol Toxicol 26:79–86. https://doi.org/10.1002/jbt.20412
Cheng J et al (2013) An extensive network of TET2-targeting MicroRNAs regulates malignant hematopoiesis. Cell Rep 5:471–481. https://doi.org/10.1016/j.celrep.2013.08.050
Coutinho-Camillo CM, Lourenco SV, de Araujo LL, Kowalski LP, Soares FA (2015) Expression of apoptosis-regulating miRNAs and target mRNAs in oral squamous cell carcinoma. Cancer Genet 208:382–389. https://doi.org/10.1016/j.cancergen.2015.04.004
Darido C et al (2011) Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis. Cancer Cell 20:635–648. https://doi.org/10.1016/j.ccr.2011.10.014
Du H et al (2016) YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex. Nat Commun 7:12626. https://doi.org/10.1038/ncomms12626
Fabbri M et al (2007) MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A 104:15805–15810. https://doi.org/10.1073/pnas.0707628104
Fabian MR, Sonenberg N, Filipowicz W (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79:351–379. https://doi.org/10.1146/annurev-biochem-060308-103103
Fan K et al (2018) Circulating cell-free miR-375 as surrogate marker of tumor burden in merkel cell carcinoma. Clin Cancer Res 24:5873–5882. https://doi.org/10.1158/1078-0432.CCR-18-1184
Fang C et al (2012) Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma. Ann Hematol 91:553–559. https://doi.org/10.1007/s00277-011-1350-9
Gao JM, Huang LZ, Huang ZG, He RQ (2018) Clinical value and potential pathways of miR-183-5p in bladder cancer: a study based on miRNA-seq data and bioinformatics analysis. Oncol Lett 15:5056–5070. https://doi.org/10.3892/ol.2018.7967
Garcia-Sancha N, Corchado-Cobos R, Perez-Losada J, Canueto J (2019) MicroRNA dysregulation in cutaneous squamous cell carcinoma. Int J Mol Sci 20:2181. https://doi.org/10.3390/ijms20092181
Garzon R et al (2008) Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci U S A 105:3945–3950. https://doi.org/10.1073/pnas.0800135105
Giles KM et al (2016) microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-kappaB. Oncotarget 7:31663–31680. https://doi.org/10.18632/oncotarget.9421
Glogau RG (2000) The risk of progression to invasive disease. J Am Acad Dermatol 42:23–24. https://doi.org/10.1067/mjd.2000.103339
Greussing R et al (2013) Identification of microRNA-mRNA functional interactions in UVB-induced senescence of human diploid fibroblasts. BMC Genomics 14:224. https://doi.org/10.1186/1471-2164-14-224
Gu Z, Eils R, Schlesner M (2016) Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32:2847–2849. https://doi.org/10.1093/bioinformatics/btw313
Harada M et al (2017) The expression of miR-124 increases in aged skin to cause cell senescence and it decreases in squamous cell carcinoma. Biosci Trends 10:454–459. https://doi.org/10.5582/bst.2016.01102
Heinzelmann J et al (2011) Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma. World J Urol 29:367–373. https://doi.org/10.1007/s00345-010-0633-4
Hollestein LM, de Vries E, Nijsten T (2012) Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989–2008. Eur J Cancer 48:2046–2053. https://doi.org/10.1016/j.ejca.2012.01.003
Ikeda Y, Tanji E, Makino N, Kawata S, Furukawa T (2012) MicroRNAs associated with mitogen-activated protein kinase in human pancreatic cancer. Mol Cancer Res 10:259–269. https://doi.org/10.1158/1541-7786.MCR-11-0035
Issler MVC, Mombach JCM (2017) MicroRNA-16 feedback loop with p53 and Wip1 can regulate cell fate determination between apoptosis and senescence in DNA damage response. PLoS ONE 12:e0185794. https://doi.org/10.1371/journal.pone.0185794
Jaskowiak PA, Campello RJ, Costa IG (2014) On the selection of appropriate distances for gene expression data clustering. BMC Bioinformatics 15(Suppl 2):S2. https://doi.org/10.1186/1471-2105-15-S2-S2
Jiang L et al (2010) MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. Biochem J 432:199–205. https://doi.org/10.1042/BJ20100859
Jung HM et al (2012) Keratinization-associated miR-7 and miR-21 regulate tumor suppressor reversion-inducing cysteine-rich protein with kazal motifs (RECK) in oral cancer. J Biol Chem 287:29261–29272. https://doi.org/10.1074/jbc.M112.366518
Kong X et al (2012) MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression. PLoS ONE 7:e41523. https://doi.org/10.1371/journal.pone.0041523
Kraemer A et al (2013) UVA and UVB irradiation differentially regulate microRNA expression in human primary keratinocytes. PLoS ONE 8:e83392. https://doi.org/10.1371/journal.pone.0083392
Kwon JJ, Factora TD, Dey S, Kota J (2019) A Systematic review of miR-29 in cancer. Mol Ther Oncolytics 12:173–194. https://doi.org/10.1016/j.omto.2018.12.011
Lan H, Lu H, Wang X, Jin H (2015) MicroRNAs as potential biomarkers in cancer: opportunities and challenges. Biomed Res Int 2015:125094. https://doi.org/10.1155/2015/125094
Li CY et al (2017) Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression. Clin Transl Oncol 19:162–172. https://doi.org/10.1007/s12094-016-1516-y
Li G, Li L, Sun Q, Wu J, Ge W, Lu G, Cai M (2018a) MicroRNA-3200-5p promotes osteosarcoma cell invasion via suppression of BRMS1. Mol Cells 41:523–531. https://doi.org/10.14348/molcells.2018.2200
Li W, Zhang T, Guo L, Huang L (2018b) Regulation of PTEN expression by noncoding RNAs. J Exp Clin Cancer Res 37:223. https://doi.org/10.1186/s13046-018-0898-9
Li Y, Liu Y, Xie P, Li F, Li G (2014) PAX6, a novel target of microRNA-7, promotes cellular proliferation and invasion in human colorectal cancer cells. Dig Dis Sci 59:598–606. https://doi.org/10.1007/s10620-013-2929-x
Li YY, Hanna GJ, Laga AC, Haddad RI, Lorch JH, Hammerman PS (2015) Genomic analysis of metastatic cutaneous squamous cell carcinoma. Clin Cancer Res 21:1447–1456. https://doi.org/10.1158/1078-0432.CCR-14-1773
Liang G, Li G, Wang Y, Lei W, Xiao Z (2014) Aberrant miRNA expression response to UV irradiation in human liver cancer cells. Mol Med Rep 9:904–910. https://doi.org/10.3892/mmr.2014.1901
Liu HT, Gao P (2016) The roles of microRNAs related with progression and metastasis in human cancers. Tumour Biol. https://doi.org/10.1007/s13277-016-5436-9
Liu Q, Geng P, Shi L, Wang Q, Wang P (2019a) miR-29 promotes osteosarcoma cell proliferation and migration by targeting PTEN. Oncol Lett 17:883–890. https://doi.org/10.3892/ol.2018.9646
Liu S, Zhang P, Chen Z, Liu M, Li X, Tang H (2013) MicroRNA-7 downregulates XIAP expression to suppress cell growth and promote apoptosis in cervical cancer cells. FEBS Lett 587:2247–2253. https://doi.org/10.1016/j.febslet.2013.05.054
Liu T, Wang Y, Chan AM (2019b) Multifaceted regulation of PTEN subcellular distributions and biological functions. Cancers (Basel) 11:1247. https://doi.org/10.3390/cancers11091247
Liu Z, Jiang Z, Huang J, Huang S, Li Y, Yu S, Liu X (2014) miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways. Int J Oncol 44:1571–1580. https://doi.org/10.3892/ijo.2014.2322
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408. https://doi.org/10.1006/meth.2001.1262
Lowery AJ, Miller N, Dwyer RM, Kerin MJ (2010) Dysregulated miR-183 inhibits migration in breast cancer cells. BMC Cancer 10:502. https://doi.org/10.1186/1471-2407-10-502
Lujambio A, Lowe SW (2012) The microcosmos of cancer. Nature 482:347–355. https://doi.org/10.1038/nature10888
Ma L (2016) MicroRNA and metastasis. Adv Cancer Res 132:165–207. https://doi.org/10.1016/bs.acr.2016.07.004
Meza-Sosa KF, Perez-Garcia EI, Camacho-Concha N, Lopez-Gutierrez O, Pedraza-Alva G, Perez-Martinez L (2014) MiR-7 promotes epithelial cell transformation by targeting the tumor suppressor KLF4. PLoS ONE 9:e103987. https://doi.org/10.1371/journal.pone.0103987
Miao F, Zhu J, Chen Y, Tang N, Wang X, Li X (2016) MicroRNA-183-5p promotes the proliferation, invasion and metastasis of human pancreatic adenocarcinoma cells. Oncol Lett 11:134–140. https://doi.org/10.3892/ol.2015.3872
Mittelbronn MA, Mullins DL, Ramos-Caro FA, Flowers FP (1998) Frequency of pre-existing actinic keratosis in cutaneous squamous cell carcinoma. Int J Dermatol 37:677–681
Nouraee N, Calin GA (2013) MicroRNAs as cancer biomarkers. Microrna 2:102–117
Ogata D, Tsuchida T (2019) Systemic immunotherapy for advanced cutaneous squamous cell carcinoma. Curr Treat Options Oncol 20:30. https://doi.org/10.1007/s11864-019-0629-2
Okuda H et al (2013) miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4. Cancer Res 73:1434–1444. https://doi.org/10.1158/0008-5472.CAN-12-2037
Oliveto S, Mancino M, Manfrini N, Biffo S (2017) Role of microRNAs in translation regulation and cancer. World J Biol Chem 8:45–56. https://doi.org/10.4331/wjbc.v8.i1.45
Pfeffer SR et al (2015) Detection of exosomal miRNAs in the plasma of melanoma patients. J Clin Med 4:2012–2027. https://doi.org/10.3390/jcm4121957
Pickering CR et al (2014) Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin Cancer Res 20:6582–6592. https://doi.org/10.1158/1078-0432.CCR-14-1768
Popp S, Waltering S, Holtgreve-Grez H, Jauch A, Proby C, Leigh IM, Boukamp P (2000) Genetic characterization of a human skin carcinoma progression model: from primary tumor to metastasis. J Invest Dermatol 115:1095–1103. https://doi.org/10.1046/j.1523-1747.2000.00173.x
Pothof J et al (2009) MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response. Embo J 28:2090–2099. https://doi.org/10.1038/emboj.2009.156
Proby CM, Purdie KJ, Sexton CJ, Purkis P, Navsaria HA, Stables JN, Leigh IM (2000) Spontaneous keratinocyte cell lines representing early and advanced stages of malignant transformation of the epidermis. Exp Dermatol 9:104–117
Qiu C, Chen G, Cui Q (2012) Towards the understanding of microRNA and environmental factor interactions and their relationships to human diseases. Sci Rep 2:318. https://doi.org/10.1038/srep00318
Ratert N et al (2012) Reference miRNAs for miRNAome analysis of urothelial carcinomas. PLoS ONE 7:e39309. https://doi.org/10.1371/journal.pone.0039309
Ratushny V, Gober MD, Hick R, Ridky TW, Seykora JT (2012) From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest 122:464–472. https://doi.org/10.1172/JCI57415
Ren LH et al (2014) MicroRNA-183 promotes proliferation and invasion in oesophageal squamous cell carcinoma by targeting programmed cell death 4. Br J Cancer 111:2003–2013. https://doi.org/10.1038/bjc.2014.485
Ru P, Steele R, Newhall P, Phillips NJ, Toth K, Ray RB (2012) miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling. Mol Cancer Ther 11:1166–1173. https://doi.org/10.1158/1535-7163.MCT-12-0100
Ruan H, Liang X, Zhao W, Ma L, Zhao Y (2017) The effects of microRNA-183 promots cell proliferation and invasion by targeting MMP-9 in endometrial cancer. Biomed Pharmacother 89:812–818. https://doi.org/10.1016/j.biopha.2017.02.091
Sand M et al (2012) Expression of microRNAs in basal cell carcinoma. Br J Dermatol 167:847–855. https://doi.org/10.1111/j.1365-2133.2012.11022.x
Sarver AL, Li L, Subramanian S (2010) MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res 70:9570–9580. https://doi.org/10.1158/0008-5472.CAN-10-2074
Schmitt J et al (2018) Is ultraviolet exposure acquired at work the most important risk factor for cutaneous squamous cell carcinoma? Results of the population-based case-control study FB-181. Br J Dermatol 178:462–472. https://doi.org/10.1111/bjd.15906
Sha J et al (2016) The Response of microRNAs to Solar UVR in skin-resident melanocytes differs between melanoma patients and healthy persons. PLoS ONE 11:e0154915. https://doi.org/10.1371/journal.pone.0154915
Stojadinovic O et al (2017) MiR-21 and miR-205 are induced in invasive cutaneous squamous cell carcinomas. Arch Dermatol Res 309:133–139. https://doi.org/10.1007/s00403-016-1705-0
Tan G, Shi Y, Wu ZH (2012) MicroRNA-22 promotes cell survival upon UV radiation by repressing PTEN. Biochem Biophys Res Commun 417:546–551. https://doi.org/10.1016/j.bbrc.2011.11.160
Tengda L, Shuping L, Mingli G, Jie G, Yun L, Weiwei Z, Anmei D (2018) Serum exosomal microRNAs as potent circulating biomarkers for melanoma. Melanoma Res. https://doi.org/10.1097/CMR.0000000000000450
Ueno K et al (2013) microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer. Br J Cancer 108:1659–1667. https://doi.org/10.1038/bjc.2013.125
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034. https://doi.org/10.1186/gb-2002-3-7-research0034
Veerla S et al (2009) MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31. Int J Cancer 124:2236–2242. https://doi.org/10.1002/ijc.24183
Voiculescu V et al (2016) From normal skin to squamous cell carcinoma: a quest for novel biomarkers. Dis Markers 2016:4517492. https://doi.org/10.1155/2016/4517492
Wang L, Zhang C, Guo Y, Su ZY, Yang Y, Shu L, Kong AN (2014) Blocking of JB6 cell transformation by tanshinone IIA: epigenetic reactivation of Nrf2 antioxidative stress pathway. AAPS J 16:1214–1225. https://doi.org/10.1208/s12248-014-9666-8
Wang X et al (2017) miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma. Oncotarget 8:86592–86603. https://doi.org/10.18632/oncotarget.21246
Webster RJ, Giles KM, Price KJ, Zhang PM, Mattick JS, Leedman PJ (2009) Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. J Biol Chem 284:5731–5741. https://doi.org/10.1074/jbc.M804280200
Wu DG et al (2011) MicroRNA-7 regulates glioblastoma cell invasion via targeting focal adhesion kinase expression. Chin Med J (Engl) 124:2616–2621
Wu Q, Wang C, Lu Z, Guo L, Ge Q (2012) Analysis of serum genome-wide microRNAs for breast cancer detection. Clin Chim Acta 413:1058–1065. https://doi.org/10.1016/j.cca.2012.02.016
Wu S, Han J, Laden F, Qureshi AA (2014a) Long-term ultraviolet flux, other potential risk factors, and skin cancer risk: a cohort study. Cancer Epidemiol Biomarkers Prev 23:1080–1089. https://doi.org/10.1158/1055-9965.EPI-13-0821
Wu S, Han J, Vleugels RA, Puett R, Laden F, Hunter DJ, Qureshi AA (2014b) Cumulative ultraviolet radiation flux in adulthood and risk of incident skin cancers in women. Br J Cancer 110:1855–1861. https://doi.org/10.1038/bjc.2014.43
Wu Y, Deng W, Klinke DJ 2nd (2015) Exosomes: improved methods to characterize their morphology, RNA content, and surface protein biomarkers. Analyst 140:6631–6642. https://doi.org/10.1039/c5an00688k
Xiang F, Lucas R, Hales S, Neale R (2014) Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978–2012: empirical relationships. JAMA Dermatol 150:1063–1071. https://doi.org/10.1001/jamadermatol.2014.762
Xiao D et al (2016) Melanoma cell-derived exosomes promote epithelial-mesenchymal transition in primary melanocytes through paracrine/autocrine signaling in the tumor microenvironment. Cancer Lett 376:318–327. https://doi.org/10.1016/j.canlet.2016.03.050
Xie J et al (2014) miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression. Oncol Rep 31:1715–1722. https://doi.org/10.3892/or.2014.3052
Xu H, Cheung IY, Guo HF, Cheung NK (2009) MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7–H3: potential implications for immune based therapy of human solid tumors. Cancer Res 69:6275–6281. https://doi.org/10.1158/0008-5472.CAN-08-4517
Yan D, Cai X, Feng Y (2016) miR-183 modulates cell apoptosis and proliferation in tongue squamous cell carcinoma SCC25 cell line. Oncol Res 24:399–404. https://doi.org/10.3727/096504016X14685034103239
Yanaihara N et al (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9:189–198. https://doi.org/10.1016/j.ccr.2006.01.025
Yang F, Ning Z, Ma L, Liu W, Shao C, Shu Y, Shen H (2017) Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts. Mol Cancer 16:148. https://doi.org/10.1186/s12943-017-0718-4
Yang M et al (2014) miRNA-183 suppresses apoptosis and promotes proliferation in esophageal cancer by targeting PDCD4. Mol Cells 37:873–880. https://doi.org/10.14348/molcells.2014.0147
Yang X, Wang L, Wang Q, Li L, Fu Y, Sun J (2018) MiR-183 inhibits osteosarcoma cell growth and invasion by regulating LRP6-Wnt/beta-catenin signaling pathway. Biochem Biophys Res Commun 496:1197–1203. https://doi.org/10.1016/j.bbrc.2018.01.170
Yanofsky VR, Mercer SE, Phelps RG (2011) Histopathological variants of cutaneous squamous cell carcinoma: a review. J Skin Cancer 2011:210813. https://doi.org/10.1155/2011/210813
Yu X, Li Z (2016) The role of miRNAs in cutaneous squamous cell carcinoma. J Cell Mol Med 20:3–9. https://doi.org/10.1111/jcmm.12649
Yu Z et al (2013) Identification of miR-7 as an oncogene in renal cell carcinoma. J Mol Histol 44:669–677. https://doi.org/10.1007/s10735-013-9516-5
Zhang J, Li S, Li L, Li M, Guo C, Yao J, Mi S (2015a) Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics 13:17–24. https://doi.org/10.1016/j.gpb.2015.02.001
Zhang L et al (2015b) Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature 527:100–104. https://doi.org/10.1038/nature15376
Zhao B, Ming M, He YY (2013) Suppression of PTEN transcription by UVA. J Biochem Mol Toxicol 27:184–191. https://doi.org/10.1002/jbt.21451
Zhou BR et al (2012) Characterization of the miRNA profile in UVB-irradiated normal human keratinocytes. Exp Dermatol 21:317–319. https://doi.org/10.1111/j.1600-0625.2012.01465.x
Zhou X et al (2014) MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer. PLoS ONE 9:e96718. https://doi.org/10.1371/journal.pone.0096718
Acknowledgements
Prof. P. Boukamp for kindly providing cell lines and discussion. S. Balk, R. Börger-Hoppe, M. Brunsen, S. Engel-Haskiris and R. Keck for technical support.
Funding
This project has been financially supported by Federal Ministry of Education and Research (BMBF), Grant Number: 02NUK036B and Hiege-Stiftung gegen Hautkrebs, Grant Number: D/106-21076.
Author information
Authors and Affiliations
Contributions
All authors had input into the manuscript and have approved the manuscript for publication. Conceptualization, R.G., B.V. and J.C.B.; methodology, I-P.C, M. B., M. M.-G., I.S., A.S., and S.H.; validation, M.B.; formal analysis, M.B.; investigation, I-P.C., I.S., A.S., K.F., L.K.; writing—original draft preparation, R.G.; writing—review and editing, R.G., J.C.B, I-P.C., M.B., A.S., S.D.; visualization, M.B..; supervision, R.G and J.C.B..; project administration, I-P.C., M.B..; funding acquisition, R.G. and J.C.B.
Corresponding author
Ethics declarations
Conflicts of interest
Jürgen C. Becker has received speaker honoraria from Amgen, Merck Serono, Pfizer, and Sanofi advisory board honoraria from 4SC, Amgen, CureVac, eTheRNA, Lytix, Merck Serono, Novartis and ReProTher, as well as research funding from Alcedis, Boehringer Ingelheim, Bristol-Myers Squibb and Merck Serono; he also received travel support from 4SC and Incyte. The other authors declare no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chen, IP., Bender, M., Spassova, I. et al. UV-type specific alteration of miRNA expression and its association with tumor progression and metastasis in SCC cell lines. J Cancer Res Clin Oncol 146, 3215–3231 (2020). https://doi.org/10.1007/s00432-020-03358-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-020-03358-9